Ouadih-Moran, M.; Muñoz-Hoyos, A.; D’Marco, L.; Molina-Carballo, A.; Seiquer, I.; Checa-Ros, A.
Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs. Nutrients 2023, 15, 712.
https://doi.org/10.3390/nu15030712
AMA Style
Ouadih-Moran M, Muñoz-Hoyos A, D’Marco L, Molina-Carballo A, Seiquer I, Checa-Ros A.
Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs. Nutrients. 2023; 15(3):712.
https://doi.org/10.3390/nu15030712
Chicago/Turabian Style
Ouadih-Moran, Miriam, Antonio Muñoz-Hoyos, Luis D’Marco, Antonio Molina-Carballo, Isabel Seiquer, and Ana Checa-Ros.
2023. "Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs" Nutrients 15, no. 3: 712.
https://doi.org/10.3390/nu15030712
APA Style
Ouadih-Moran, M., Muñoz-Hoyos, A., D’Marco, L., Molina-Carballo, A., Seiquer, I., & Checa-Ros, A.
(2023). Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs. Nutrients, 15(3), 712.
https://doi.org/10.3390/nu15030712
